Two Penn seniors named 2022 Rhodes Scholars
Two Penn seniors have been awarded 2022 Rhodes Scholarships for graduate study at the University of Oxford, Raveen Kariyawasam (left), from Colombo, Sri Lanka, and Nicholas Thomas-Lewis, from Kimball, Nebraska. Kariyawasam is in the School of Engineering and Applied Sciences and the Wharton School, and Thomas-Lewis is in the College of Arts and Sciences.
Penn’s 2022 Rhodes Scholars are Raveen Kariyawasam, from Colombo, Sri Lanka, and Nicholas Thomas-Lewis, from Kimball, Nebraska.
Kariyawasam is a double major in bioengineering with concentrations in computational medicine and medical devices in the School of Engineering and Applied Science and in the Wharton School with concentrations in finance and entrepreneurship and innovation.
Thomas-Lewis is a double major in cognitive science with a concentration in cognitive neuroscience, as well as health and societies with a concentration in public health, and a minor in neuroscience, in the College of Arts and Sciences.
“We are so proud of our newest Penn Rhodes Scholars who have been chosen for this tremendous honor and opportunity,” said President Amy Gutmann. “The work Raveen has done in health care innovation and accessibility and Nicholas has done to support student well-being while at Penn is impressive, and pursuing a graduate degree at Oxford will build upon that foundation. We look forward to seeing how they make an impact in the future.”
The Rhodes is highly competitive and one of the most prestigious scholarships in the world. The scholarships provide all expenses for as long as four years of study at Oxford University in England.
According to the Rhodes Trust, about 100 Rhodes Scholars will be selected worldwide this year, chosen from more than 60 countries. Several have attended American colleges and universities but are not U.S. citizens and have applied through their home country, including Kariyawasam in Sri Lanka.
Thomas-Lewis is among the 32 American Rhodes Scholars chosen to represent the United States. According to the Rhodes Trust, this year more than 2,300 American students began the application process, 826 were endorsed by 247 different colleges and universities, and 235 applicants from 76 colleges and universities reached the final stage of the competition.
Thomas-Lewis’s honors thesis is on the dual neurocentric medicalization of adolescence and addiction and its impact on stigma and agency among adolescents with addiction. He is a mentor who supports literacy development and emotional well being in West Philadelphia elementary schools through the Netter Center for Community Partnerships. Thomas-Lewis is captain of Penn’s varsity cheer team. He is a former speech captain for Penn Speech and Debate club. Thomas-Lewis also serves as a campus guide for the Kite & Key Society, is a vocal performer with the Penny Loafers, and is co-chair of the Admissions Dean’s Advisory Board. At Oxford, Thomas-Lewis plans to pursue master’s degrees in evidence-based social intervention and policy evaluation and in medical anthropology.
When the Schuylkill swallowed the city: Lessons from Hurricane Ida’s historic flood
New Penn research shows that Hurricane Ida wasn’t a once-in-a-century anomaly but a preview of how climate change, urbanization, and aging infrastructure are rewriting flood risk.
The Fed explained: What it does and why it matters
Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy
How population changes are impacting primary education worldwide
Research from Penn sociologist Emily Hannum and colleagues reveals regional trends in whether school-age populations are increasing, plateauing, or decreasing—and shows how different countries are responding.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
